CBGL (Cannabis Global) Total Liabilities: $7.29 Mil (As of May. 2022)


What is Cannabis Global Total Liabilities?

Cannabis Global CBGL Total Liabilities is $7.29 Mil as of May. 2022.

Cannabis Global's Total Liabilities for the quarter that ended in May. 2022 was $7.29 Mil.

Cannabis Global's quarterly Total Liabilities declined from Nov. 2021 ($7.38 Mil) to Feb. 2022 ($7.22 Mil) but then increased from Feb. 2022 ($7.22 Mil) to May. 2022 ($7.29 Mil).

Cannabis Global's annual Total Liabilities increased from Aug. 2019 ($0.15 Mil) to Aug. 2020 ($3.76 Mil) and increased from Aug. 2020 ($3.76 Mil) to Aug. 2021 ($9.98 Mil).


Cannabis Global Total Liabilities Historical Data

* Premium members only.

The historical data trend for Cannabis Global's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cannabis Global Total Liabilities Chart

Cannabis Global Annual Data
Trend Aug12 Aug13 Aug14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.09 0.14 0.15 3.76 9.98

Cannabis Global Quarterly Data
Aug17 Nov17 Feb18 May18 Aug18 Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.67 9.98 7.38 7.22 7.29

Cannabis Global Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Cannabis Global's Total Liabilities for the fiscal year that ended in Aug. 2021 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=8.747+(1.236+6.6613381477509E-16
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=9.98

Total Liabilities=Total Assets (A: Aug. 2021 )-Total Equity (A: Aug. 2021 )
=11.339-1.356
=9.98

Cannabis Global's Total Liabilities for the quarter that ended in May. 2022 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=6.114+(1.174+-0.00099999999999989
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=7.29

Total Liabilities=Total Assets (Q: May. 2022 )-Total Equity (Q: May. 2022 )
=14.909-7.621
=7.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $7.29 Mil mean?
Cannabis Global (CBGL) has a Total Liabilities of $7.29 Mil as of May. 2022. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Cannabis Global and its competitors.
Is Cannabis Global's Total Liabilities too high?
Cannabis Global's current Total Liabilities is $7.29 Mil.
How does Cannabis Global's Total Liabilities compare to MILC and BBBT?
Cannabis Global's Total Liabilities of $7.29 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Drug Manufacturers company?
A good Total Liabilities depends on the Drug Manufacturers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Cannabis Global and its competitors. Cannabis Global's current Total Liabilities is $7.29 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cannabis Global stock overvalued right now?
Cannabis Global (CBGL) has a current Total Liabilities of $7.29 Mil. The current Total Liabilities is $7.29 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Cannabis Global (CBGL), the current Total Liabilities is $7.29 Mil as of May. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cannabis Global Business Description

Address 520 S Grand Avenue, Suite 320, Los Angeles, CA, USA, 90071
Cannabis Global Inc manufactures and distributes various cannabis products via its majority ownership of Natural Plant Extract, Inc is developing the Ethos Comply Bag, and generally conducts research and development in the areas of hemp, cannabis and consumer food goods. The company also have an active research and development program focused on creating and commercializing engineered technologies that deliver hemp extracts and cannabinoids to the human body. Its product includes cannabis flower packaged in various weights, cannabis Pre-rolls, cannabis edible products.